Authors
Loading...
New replicons enable persistent noncytopathic expression in vitro; leaves open utility for cardiovascular gene delivery research.
Key points are not available for this paper at this time.
Agapov et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: